NCT00817115

Brief Summary

The aim of the proposed study is to compare the exposure dose and diagnostic performance of region-of-interest fluoroscopy compared to standard fluoroscopy in patients and interventionists during cardiac interventional procedures. It is hypothesized that systematic application of x-ray attenuation will significantly reduce the radiation exposure of the interventional procedure while maintaining image quality, thereby decreasing risk to the patient.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P75+ for phase_1 cardiovascular-diseases

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2008

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 6, 2009

Completed
26 days until next milestone

Study Start

First participant enrolled

February 1, 2009

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
Last Updated

August 7, 2009

Status Verified

January 1, 2009

Enrollment Period

10 months

First QC Date

November 14, 2008

Last Update Submit

August 6, 2009

Conditions

Keywords

Region-of-Interest ImagingX-ray Fovea ImagingCardiovascular DiseasesRadiation DosageRadiographic Image EnhancementRadiography, Interventional

Outcome Measures

Primary Outcomes (1)

  • X-ray exposure area product, primary and scatter radiation to patient and interventionist and procedure and irradiation time for interventions performed without and with region-of-interest imaging (control and experimental arms, respectively).

    The outcome measure will be recorded per patient procedure. A comparison between control and experimental arms will be conducted after the pilot study (at ~1 to 2 months) and at end the full study (at ~4 to 6 months).

Secondary Outcomes (1)

  • Quality and diagnostic benefit of images obtained without and with the region-of-interest imaging.

    Retrospective expert comparison of images from patient procedures (between control and experimental arms) will occur within 1 to 3 months after the completion of the pilot study and the full study.

Study Arms (2)

1

NO INTERVENTION

Subjects undergoing routine cardiac catheterization or interventional procedures using the standard fluoroscopy system.

2

EXPERIMENTAL

Subjects undergoing routine cardiac catheterization or interventional procedures using the region-of-interest fluoroscopy (x-ray fovea imaging) system.

Device: Region-of-Interest Imaging (X-ray Fovea Imaging)

Interventions

Use of an experimental fluoroscopy system fitted with a region-of-interest attenuator (fovea) to evaluate or treat lesions during cardiac interventional procedures.

2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The subject is greater than 18 years of age.
  • The subject is currently planned for conventional cardiac interventional procedures (i.e. catheterization, percutaneous coronary intervention (PCI), electrophysiology (EP) ablations and procedures) as specified by his/her physician.
  • The subject is able and willing to comply with study procedures, and signed and dated informed consent is obtained.

You may not qualify if:

  • The subject is pregnant or trying to become pregnant.
  • The subject requires urgent/emergent cardiac catheterization, PCI, and/or EP procedures as per treating physician.
  • The subject has been previously included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sunnybrook Health Sciences Centre

Toronto, Ontario, M4N 3M5, Canada

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Study Officials

  • Alexander J Dick, MD

    Sunnybrook Health Sciences Centre

    PRINCIPAL INVESTIGATOR
  • Normand Robert, PhD

    Sunnybrook Health Sciences Centre

    STUDY DIRECTOR
  • John A Rowlands, PhD

    Sunnybrook Health Sciences Centre

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 14, 2008

First Posted

January 6, 2009

Study Start

February 1, 2009

Primary Completion

December 1, 2009

Last Updated

August 7, 2009

Record last verified: 2009-01

Locations